Porous polymer particles and protein purification column using the same

Porous polymer particles with controlled pore sizes and epoxy content address the inefficiencies of conventional resins, achieving superior protein purification by ensuring uniformity and high production efficiency.

JP2024541002AActive Publication Date: 2024-11-06LG CHEM LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
JP2024524466
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-09-13
Filing Date
2023-09-14
Publication Date
2024-11-06
Estimated Expiration
2043-09-14

AI Technical Summary

Technical Problem

Existing protein purification resins face issues such as low efficiency due to swelling, non-specific protein adsorption, and size deviations, leading to reduced separation and purification performance.

Method used

Development of porous polymer particles with controlled pore sizes (50 nm to 500 nm) and epoxy content (500 μmol to 5000 μmol) for enhanced protein purification, using a method that includes a polymer matrix with specific monomers and pore-inducing substances to ensure uniform particle size and high production efficiency.

Benefits of technology

The porous polymer particles provide improved protein purification performance by ensuring adequate surface area and uniformity, enhancing the separation and purification efficiency in protein purification columns.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541002000001_ABST
    Figure 2024541002000001_ABST
Patent Text Reader

Abstract

The present invention relates to porous polymer particles comprising: a polymer matrix; and pores dispersed in the polymer matrix and having a diameter of 50 nm to 500 nm; wherein the epoxy content contained in 1 g of the porous polymer particles is 500 μmol or more and less than 5,000 μmol; and a protein purification column using the same.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of priority based on Korean Patent Application No. 10-2022-0117461 dated September 16, 2022 and Korean Patent Application No. 10-2023-0121985 dated September 13, 2023, and all contents disclosed in the documents of said Korean patent applications are incorporated herein by reference.

[0002] The present invention relates to a porous polymer particle and a protein purification column using the same. [Background technology]

[0003] With the expansion of the fields of biopharmaceuticals and regenerative medicine, there is a growing need for systems that can efficiently separate or purify cells, tissues, microorganisms, etc.

[0004] In conventional technology, purification resins made from hydrophilic agarose were mainly used, but such resins swelled with buffer during the purification process, reducing their strength, resulting in low purification speed and efficiency.

[0005] In contrast, when synthetic polymers are used as resins for protein purification, they have the advantage of being stronger than agarose, but if the synthetic polymers have low sphericity and large particle size deviation, differences in the migration path of the separated (or purified) products occur, resulting in low separation efficiency. In addition, there is also the problem that proteins are nonspecifically adsorbed due to the surface properties of the synthetic polymers, resulting in low purification efficiency.

[0006] Therefore, there has been active research into technologies for producing polymer particles suitable for use in protein purification resins, and recently, research has been conducted on emulsification devices capable of forming fine emulsion droplets for producing polymer particles. Fine emulsion droplets are formed by dispersing one type of fluid inside another type of fluid, for example, water and oil, which have low affinity and do not mix with each other. Representative emulsions include water-in-oil (W / O) emulsions, in which water droplets are dispersed inside oil, and oil-in-water (O / W) emulsions, in which oil is dispersed inside water.

[0007] An emulsification device for producing such emulsion droplets is made by bonding two substrates together, one of which has a flow path of a set shape formed thereon, and the other substrate has an inlet for injecting oil and water into the flow path.

[0008] However, in the case of conventionally produced polymer particles, the pore-forming material injected to form pores has a high viscosity and is absorbed in the emulsifier, making it difficult to reuse, resulting in a decrease in production speed. Summary of the Invention [Problem to be solved by the invention]

[0009] The present invention provides porous polymer particles which are produced by a method with high productivity and have a particle size and pore size suitable for achieving high protein purification performance in a protein purification column.

[0010] The present invention also provides a protein purification column comprising the porous polymer particles. [Means for solving the problem]

[0011] In order to solve the above problems, the present specification provides porous polymer particles comprising: a polymer matrix; and pores dispersed in the polymer matrix and having a diameter of 50 nm to 500 nm; wherein the epoxy content per 1 g of the porous polymer particles measured by the following Equation 1 is 500 μmol or more and less than 5,000 μmol.

[0012] [Formula 1] Epoxy content (μmol / g)=[(V0-V)×C 塩基 ×1000] / W

[0013] In the above formula 1, V is the amount (mL) of base used in titrating the experimental sample containing the porous polymer particles, V0 is the amount (mL) of base used in titrating the control sample in which distilled water is used instead of the porous polymer particles in the experimental sample, and C 塩基 is the concentration of the base used in the titration (M), and W is the mass of the porous polymer particles used in the titration (g).

[0014] Also provided herein is a protein purification column comprising the porous polymer particles.

[0015] Hereinafter, a porous polymer particle according to a specific embodiment of the present invention and a protein purification column using the same will be described in more detail.

[0016] Unless otherwise expressly stated herein, the terminology used is for the purpose of referring to particular embodiments only and is not intended to be limiting of the invention.

[0017] As used herein, the singular forms "a," "an," and "the" include the plural forms unless the context clearly dictates to the contrary.

[0018] As used herein, the meaning of "comprising" is to embody certain features, regions, integers, steps, operations, elements, components and / or components, and does not exclude the presence or addition of other certain features, regions, integers, steps, operations, elements, components and / or groups.

[0019] In this specification, terms including ordinal numbers such as "first" and "second" are used for the purpose of distinguishing one component from another component, and are not limited by the ordinal number. For example, within the scope of the present invention, a first component may be named a second component, and similarly, a second component may be named a first component.

[0020] As used herein, "porous particles" can refer to particles that have pores inside and / or on the surface of the particle.

[0021] In this specification, the term "(meth)acrylate" is intended to include both acrylate and methacrylate.

[0022] Unless otherwise defined or described herein, the temperature at which the manufacturing process (or each manufacturing step) is carried out or the temperature at which the numerical properties of the manufactured particles are calculated or measured is room temperature. Specifically, in the present application, "room temperature" refers to a temperature in a state where the temperature is not particularly increased or decreased, and may refer to a temperature in the range of, for example, 15°C to 30°C, or 20°C to 30°C.

[0023] In this specification, examples of the substituents are described below, but the present invention is not limited thereto.

[0024] In this specification, the term "substituted" means that another functional group is bonded in place of a hydrogen atom in a compound, and the position of the substitution is not limited as long as it is a position at which a hydrogen atom is substituted, i.e., a position at which a substituent can be substituted, and when two or more substitutions are made, the two or more substituents may be the same or different.

[0025] In the present specification, the term "substituted or unsubstituted" means that the group is substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium, halogen, cyano, nitro, hydroxy, carbonyl, ester, imide, amide, primary amino, carboxy, sulfonic acid, sulfonamide, phosphine oxide, alkoxy, aryloxy, alkylthio, arylthio, alkylsulfoxy, arylsulfoxy, silyl, boron, alkyl, cycloalkyl, alkenyl, aryl, aralkyl, aralkenyl, alkylaryl, alkoxysilylalkyl, arylphosphine, or heterocyclic groups containing one or more N, O, and S atoms, or that the group is substituted or unsubstituted with two or more of the above-listed substituents. For example, the "substituent with two or more substituents connected" may be a biphenyl group. In other words, the biphenyl group may be an aryl group, and may be interpreted as a substituent with two phenyl groups connected.

[0026] In this specification, aromaticity refers to a property that satisfies the Huckels Rule, and according to the Huckels Rule, something that satisfies all of the following three conditions can be defined as aromatic.

[0027] 1) There must be 4n+2 electrons present that are fully conjugated by hollow p-orbitals, unsaturated bonds, hole electron pairs, etc. 2) The 4n+2 electrons must form a planar isomer and must form a ring structure. 3) All atoms of the ring must be able to participate in conjugation.

[0028] As used herein, aliphatic refers to the remaining organic compounds excluding the aromatics defined above.

[0029] In this specification, the alkyl group is a monovalent functional group derived from an alkane, which may be linear or branched, and the number of carbon atoms in the linear alkyl group is not particularly limited, but is preferably 1 to 20. Also, the number of carbon atoms in the branched alkyl group is 3 to 20. Exemplary alkyl groups include, but are not limited to, methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methyl-butyl, 1-ethyl-butyl, pentyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl, n-heptyl, 1-methylhexyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2-dimethylheptyl, 1-ethyl-propyl, 1,1-dimethyl-propyl, isohexyl, 2-methylpentyl, 4-methylhexyl, 5-methylhexyl, 2,6-dimethylheptan-4-yl, and the like. The alkyl group may be substituted or unsubstituted, and when substituted, examples of the substituents are as described above.

[0030] The present invention will now be described in more detail.

[0031] 1.Porous polymer particles According to one embodiment of the present invention, there is provided a porous polymer particle comprising: a polymer matrix; and pores dispersed in the polymer matrix and having a diameter of 50 nm to 500 nm; wherein the epoxy content per 1 g of the porous polymer particle measured by the following Equation 1 is 500 μmol or more and less than 5,000 μmol.

[0032] [Formula 1] Epoxy content (μmol / g)=[(V o -V)×C 塩基 ×1000] / W

[0033] In the above formula 1, V is the amount (mL) of base used in titrating the experimental sample containing the porous polymer particles, and V o is the amount (mL) of base used in titrating the control sample in which distilled water was used instead of the porous polymer particles in the experimental sample, and C 塩基 is the concentration of the base used in the titration (M), and W is the mass of the porous polymer particles used in the titration (g).

[0034] The present inventors have confirmed through experiments that the porous polymer particles of one embodiment of the present invention have pores with diameters of 50 nm to 500 nm distributed in the particles, providing a large surface area and making them suitable for use as particles for protein purification used in the production of pharmaceuticals through processes such as ligand attachment, thereby completing the invention.

[0035] In particular, since the pores are derived from one single pore-inducing material as described below, the particle manufacturing process is simplified, and since the one single pore-inducing material has low viscosity, it passes through a step emulsifier at a fast speed, thereby increasing process efficiency.

[0036] In addition, the single pore-inducing material that forms the pores has appropriate miscibility with the monomers, crosslinkers and polymers that form the polymer matrix, and can stably form pores of the appropriate size range described above during polymerization of the porous polymer particles.

[0037] On the other hand, the inventors confirmed through experiments that it is possible to achieve an equivalent or superior level of protein purification efficiency compared to the conventional method of mixing two or more stomatal inducers, thereby completing the invention.

[0038] Furthermore, when the pores are induced from a pore-inducing substance containing a mixture of an alcohol-based compound and an aromatic hydrocarbon-based compound, pores with completely different pore characteristics can be introduced compared to when only one alcohol-based compound or one aromatic hydrocarbon-based compound is used as in the past, and optimal performance can be achieved for application to particles for protein purification used in the production of pharmaceuticals through processes such as ligand attachment.

[0039] Additionally, the porous polymer particles of one embodiment are manufactured using a step emulsifier, allowing for the production of uniformly sized particles, thereby maximizing particle performance.

[0040] Specifically, the porous polymer particles of one embodiment may include a polymer matrix, which acts as a substrate, body or binder for the porous polymer particles, and pores may be distributed inside or outside the matrix.

[0041] The polymer matrix may include a repeating unit derived from a monomer. The repeating unit derived from a monomer is a repeating unit contained in a polymer formed by polymerization of a monomer compound, and the monomer is not particularly limited. For example, the monomer is a monomer containing an epoxy group, and glycidyl methacrylate, glycidyl acrylate, or glycidyl acrylamide may be used alone or in combination with a monomer not containing an epoxy group.

[0042] Examples of the monomer not containing an epoxy group include methyl methacrylate, methyl acrylate, ethyl acrylate, ethyl hexyl acrylate, butyl acrylate, hydroxyethyl methacrylate, trimethylolpropane triacrylate, N-isopropylacrylamide, and N-butyl acrylate.

[0043] The polymer matrix may further include a repeating unit derived from a crosslinking agent. The type of the crosslinking agent is not particularly limited, and for example, a multifunctional (meth)acrylate such as ethylene glycol dimethyl (meth)acrylate, ethylene glycol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, or dipentaerythritol hexa(meth)acrylate may be used. Alternatively, one or more of the crosslinking agents listed above may be used together. When considering the formation of a hydrophilic surface of the particles, it is preferable to use ethylene glycol di(meth)acrylate.

[0044] Meanwhile, the porous polymer particles of one embodiment may include pores. The pores are derived from one or two pore-inducing materials described below. The pore-inducing material (porogen) is contained in droplets, which are particle precursors used in the process of producing porous polymer particles, and is converted into pores during the pore-forming process of forming porous polymer particles from the droplets.

[0045] Furthermore, when the pores are induced from a pore-inducing substance containing a mixture of an alcohol-based compound and an aromatic hydrocarbon-based compound, pores with completely different pore characteristics can be introduced compared to when only one alcohol-based compound or one aromatic hydrocarbon-based compound is used as in the past, and optimal performance can be achieved for application to particles for protein purification used in the production of pharmaceuticals through processes such as ligand attachment.

[0046] The pores may be dispersed throughout the polymer matrix. The pores may be dispersed within or outside the matrix.

[0047] The pores may have a diameter of 50 nm to 500 nm, or 50 nm to 400 nm, or 50 nm to 300 nm, or 50 nm to 250 nm, or 50 nm to 200 nm, or 100 nm to 400 nm. In particular, the pore diameter may be a value measured for pores formed inside or on the surface of the porous polymer particle, and the measurement method is not limited, but can be measured, for example, by SEM.

[0048] Specifically, the porous polymer particles may have a pore size on the particle surface measured by SEM of 50 nm to 500 nm, or 50 nm to 400 nm, or 50 nm to 300 nm, or 50 nm to 250 nm, or 50 nm to 200 nm, or 100 nm to 400 nm.

[0049] The pore diameter may refer to the distance between two points where a line passing through the center of gravity of the pore shape meets the boundary line of the pore for each of various shapes of pores. That is, when the pore has a diameter of 50 nm to 500 nm, it means that the pore diameter is a maximum of 500 nm or less and a minimum of 50 nm or more.

[0050] As a result, the porous polymer particles provide a large surface area and are suitable for use as particles for protein purification used in the manufacture of pharmaceuticals through processes such as ligand attachment. On the other hand, if the pore size is too small, such as less than 50 nm, there may be a problem that sufficient space for the ligand and target protein to attach is not secured, resulting in a deterioration in purification performance. Also, if the pore size is too large, such as more than 500 nm, there may be a problem that the strength of the particles is weakened and the specific surface area of ​​the particles is reduced, resulting in a deterioration in purification performance.

[0051] Meanwhile, in the porous polymer particles of the embodiment, the epoxy content contained in 1 g of the porous polymer particles measured by the following Equation 1 may be in the upper limit range of less than 5000 μmol, or less than 4000 μmol, or less than 3000 μmol, or less than 2700 μmol, or less than 2500 μmol, or less than 2000 μmol, or less than 1500 μmol, or less than 1300 μmol, or less than 1150 μmol, or less than 1000 μmol, and the lower limit range may be 500 μmol or more, or 800 μmol or more. The upper limit range and the lower limit range may be combined to satisfy a numerical range between the lower limit and the upper limit. An example of the numerical range between the lower limit and the upper limit may be 500 μmol or more and less than 5000 μmol.

[0052] The epoxy content means the content of epoxy functional groups contained in the polymer matrix contained in the porous polymer particles, and can be measured by a titration method according to the following Equation 1.

[0053] [Formula 1] Epoxy content (μmol) = [(V o -V)×C 塩基 ×1000] / W

[0054] In the above formula 1, V is the amount (mL) of base used in titrating the experimental sample containing the porous polymer particles, and V ois the amount (mL) of base used in titrating the control sample in which distilled water was used instead of the porous polymer particles in the experimental sample, and C 塩基 is the concentration of the base used in the titration (M), and W is the mass of the porous polymer particles used in the titration (g).

[0055] In the above formula 1, the experimental sample containing the porous polymer particles corresponds to a sample in which the porous polymer particles are dissolved in a solvent and then an indicator is added, and the specific solvent and the type of indicator can be used without any particular limitation. However, an example of the experimental sample containing the porous polymer particles is a solution in which 0.1 g of the porous polymer particles is mixed with 1 mL of HCl / acetone solution (volume ratio 1 / 40) and sonicated for 4 minutes, and an indicator solution (0.1% cresol red and 0.1% thymol blue are mixed in a volume ratio of 1:3, and the pH is adjusted to 7.0 using NaOH in a concentration range of 1 to 1000 mM) is added to the mixture.

[0056] In the above formula 1, the control sample using distilled water instead of the porous polymer particles in the experimental sample is the same as the experimental sample, except that distilled water is dissolved in the solvent instead of the porous polymer particles. An example of the control sample is a solution obtained by mixing 0.1 g of distilled water with 1 mL of HCl / acetone solution (volume ratio 1 / 40) and sonicating for 4 minutes, to which an indicator solution (0.1% cresol red and 0.1% thymol blue are mixed in a volume ratio of 1:3, and the pH is adjusted to 7.0 using NaOH at a concentration range of 1 to 1000 mM) is added.

[0057] In the above formula 1, the base used in the titration is not particularly limited, and any base generally used in the field of acid-base titration can be used without limitation. However, an example of the base used in the titration is NaOH.

[0058] The porous polymer particles according to one embodiment have an epoxy content of 500 μmol or more and less than 5,000 μmol per 1 g of the porous polymer particles as measured by Equation 1, and thus have the advantage of being able to stably form a large amount of pores in the above-mentioned appropriate range.

[0059] When the epoxy content in 1 g of the porous polymer particles measured by Equation 1 is excessively increased to, for example, 5,000 μmol or more, the polymer matrix formed by the monomer (or crosslinker) is not sufficiently performed due to the epoxy-containing monomer having low affinity with the pore-inducing material, and the pore size increases excessively, weakening the strength of the particles and reducing the specific surface area of ​​the particles, which may cause problems in terms of reduced purification performance.

[0060] In addition, if the epoxy content in 1 g of the porous polymer particles measured by Equation 1 is excessively reduced, such as to less than 500 μmol, the polymer matrix is ​​excessively formed by monomers (or crosslinkers) other than the epoxy-containing monomers that have low affinity with the pore-inducing substance, and the pore size is excessively reduced, which may result in insufficient space for the ligand and target protein to attach, resulting in reduced purification performance.

[0061] Meanwhile, the porous polymer particles may have a particle diameter of 10 μm to 150 μm, or 30 μm to 50 μm, or 35 μm to 45 μm, as measured by an optical microscope. During protein purification, the inside of a column is filled with particles for protein purification, and the substance to be purified is passed through the column. If the size of the particles for protein purification is smaller than the above range, it is difficult for reactants such as protein particles to pass through the column. If the size exceeds the above range, that is, if the size of the packing material present in the column is excessively large, a lot of empty space (space between particles) is generated in the column, so that the substance to be purified can pass through the column without adhering to the particle surface, and the purification efficiency may be low.

[0062] The particle diameter may refer to the distance between two points where a line passing through the center of gravity of a particle meets the boundary line of the particle for each particle having various shapes. That is, when the porous polymer particle has a diameter of 10 μm to 150 μm, it means that the diameter of the porous polymer particle is a maximum of 150 μm or less and a minimum of 10 μm or more.

[0063] In addition, the porous polymer particles may have a coefficient of variation of particle size measured by an optical microscope of 20% or less, or 15% or less, or 10% or less, or 7% or less, or 6.8% or less, or 0.1% or more, or 0.1% to 20%, or 0.1% to 15%, or 0.1% to 10%, or 0.1% to 7%, or 0.1% to 6.8%.

[0064] The method for measuring the coefficient of variation of the porous polymer particles is not limited, but may be determined, for example, by the following Equation 2.

[0065] [Formula 2] Coefficient of variation (%) = (Standard deviation of particle size / Average particle size) x 100

[0066] By reducing the coefficient of variation of the particle size of the porous polymer particles to the above range, the porous polymer particles can be produced with uniform size, thereby maximizing the particle performance.

[0067] In contrast, when the coefficient of variation of the particle size of the porous polymer particles is excessively increased, such as exceeding 20%, the deviation in particle size is large and non-uniform large particles are generated, which may make the particles unsuitable for use as particles for protein purification used in the production of pharmaceuticals.

[0068] Meanwhile, the porous polymer particles may be spherical particles. The spherical shape means a shape that is almost spherical, and can be seen with the naked eye, and may mean, for example, a particle shape in which the value obtained by dividing the length of the longest dimension by the average diameter is about 0.80 or more. When the particles have a spherical shape, a large surface area can be secured, and the protein purification performance can be improved.

[0069] On the other hand, the porous polymer particles may be particles for protein purification.

[0070] Meanwhile, the porous polymer particles may be a polymerization reaction product of a dispersed phase solution and a continuous phase aqueous solution containing one or two pore-inducing substances, a monomer, and a crosslinking agent. The polymerization produces porous polymer particles. Here, the polymerization is carried out at the interface between the continuous phase and the dispersed phase (i.e., the surface of the dispersed phase droplets) formed after mixing the dispersed phase solution and the continuous phase aqueous solution, and / or inside the dispersed phase.

[0071] That is, the example of the method for producing the porous polymer particles of the above embodiment is not particularly limited, but as an example, a method for producing porous polymer particles can be used that includes a step of mixing a dispersed phase solution containing one or two types of pore-inducing substances, a monomer, and a crosslinking agent, and a continuous phase aqueous solution, and polymerizing the mixture.

[0072] The dispersed phase solution refers to a composition that can form a dispersed phase (or droplets) after being mixed with a continuous phase aqueous solution. The continuous phase aqueous solution refers to a composition that can form a continuous phase after being mixed with a dispersed phase solution.

[0073] The continuous phase may be an aqueous phase. The aqueous solution that can be used as the continuous phase may be, but is not limited to, a solution containing water and an ionic surfactant or a non-ionic surfactant. For example, the ionic surfactant may be sodium dodecyl sulfate (SDS), and the non-ionic surfactant may be Tween 20, Tween 40, Tween 60, Tween 80, Triton X-100, polyvinyl alcohol (PVA), polyethylene glycol (PEG), etc. In one example, a 0.5% SDS solution can be used as the continuous phase. Although not particularly limited, the water may be distilled water or deionized water.

[0074] On the other hand, the dispersed phase is not particularly limited, but may be a substance that is insoluble in the continuous phase and can be polymerized by a subsequent crosslinking reaction. The dispersed phase solution may contain one or two pore-inducing substances, a monomer, and a crosslinking agent.

[0075] The monomer is not particularly limited, but for example, the monomer is a monomer containing an epoxy group, and glycidyl methacrylate, glycidyl acrylate, or glycidyl acrylamide may be used alone or in combination with a monomer not containing an epoxy group.

[0076] Examples of the monomer not containing an epoxy group include methyl methacrylate, methyl acrylate, ethyl acrylate, ethyl hexyl acrylate, butyl acrylate, hydroxyethyl methacrylate, trimethylolpropane triacrylate, N-isopropylacrylamide, and N-butyl acrylate.

[0077] In the dispersed phase solution, the content of the monomer may be 10% by weight to 60% by weight, or 10% by weight to 50% by weight, or 10% by weight to 40% by weight, or 17% by weight to 33% by weight, based on 100% by weight of the dispersed phase solution.

[0078] If the content of the monomer in the dispersed phase solution is excessively increased, for example, to more than 60 wt% based on 100 wt% of the dispersed phase solution, the epoxy content in 1 g of the porous polymer particle measured by Equation 1 will be excessively increased, for example, to more than 5,000 μmol, and the polymer matrix formed by the monomer (or crosslinker) will not be sufficiently formed due to the epoxy-containing monomer having low affinity with the pore-inducing material, and the pore size will be excessively increased, weakening the strength of the particles and reducing the specific surface area of ​​the particles, which may result in a problem of reduced purification performance.

[0079] In addition, if the content of the monomer in the dispersed phase solution is excessively reduced, for example, to less than 10 wt % based on 100 wt % of the dispersed phase solution, the epoxy content in 1 g of the porous polymer particle measured by Equation 1 is excessively reduced, for example, to less than 500 μmol, and the polymer matrix is ​​excessively formed by monomers (or crosslinkers) other than the epoxy-containing monomer that have low affinity with the pore-inducing substance, resulting in an excessive reduction in pore size, which may result in insufficient space for the attachment of the ligand and target protein, resulting in a deterioration in purification performance.

[0080] The type of the crosslinking agent is not particularly limited, and for example, polyfunctional (meth)acrylates such as ethylene glycol dimethyl (meth)acrylate, ethylene glycol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, or dipentaerythritol hexa(meth)acrylate can be used. Alternatively, one or more of the crosslinking agents listed above may be used together. When considering the formation of a hydrophilic surface of the particles, it is preferable to use ethylene glycol di(meth)acrylate.

[0081] In the dispersed phase solution, the content of the crosslinker may be 10% by weight to 60% by weight, or 10% by weight to 50% by weight, or 10% by weight to 40% by weight, or 17% by weight to 37% by weight, based on 100% by weight of the dispersed phase solution.

[0082] In one example, the dispersed phase may be a solution in which glycidyl methacrylate (GMA) and ethylene glycol dimethacrylate (EGDMA) are mixed in a mass ratio of 5:1 to 1:5, or 4:1 to 1:4, or 3:1 to 1:3, or 2:1 to 1:2.

[0083] That is, the content ratio of the crosslinking agent to 1 part by weight of the monomer may be 0.1 to 10 parts by weight, or 0.5 to 2 parts by weight. When the content is within the above range, it is advantageous to stably form an emulsion and ensure particle strength and morphological characteristics due to crosslinking at a desired level.

[0084] Meanwhile, the pore-inducing substance may include one single compound or a mixture of two kinds. In the dispersed phase solution, the content of one or two kinds of pore-inducing substances may be 10% by weight to 80% by weight, or 20% by weight to 80% by weight, or 40% by weight to 80% by weight, or 45% by weight to 80% by weight, or 44% by weight to 55% by weight based on 100% by weight of the dispersed phase solution.

[0085] If the content of the pore-inducing material is too low, less than 10 wt%, the average diameter of the pores in the porous polymer particles is too low, making it difficult to secure sufficient space for protein binding. On the other hand, if the content of the pore-inducing material is too high, more than 80 wt%, the average diameter of the pores in the porous polymer particles is too high, making it difficult to secure the strength of the particles.

[0086] The one pore-inducing material has a viscosity of 0.5cP to 15cP, or 0.8cP to 15cP, or 0.8cP to 10cP, or 0.8cP to 5cP, or 0.8cP to 1.5cP, or 0.8cP to 1.2cP, measured at 20° C. Since the one single pore-inducing material has a low viscosity, it passes through a step emulsification device at a fast speed, thereby increasing process efficiency.

[0087] The method for measuring the viscosity is not particularly limited, and conventional viscosity measuring methods can be applied without limitation. However, to explain by way of example, the viscosity can be measured at a temperature of 20 to 25°C by attaching a spindle No. 61 for low viscosity measurement to a Brookfield viscometer DV2T device, and at a fixed RPM of 200. However, the method is not necessarily limited to this, and generally, if the RPM value is the same and the viscosity range of the sample (e.g., solution) to be measured is about 10 to 1000 cp, the viscosity can be measured by other measuring devices.

[0088] The one stomatal inducer may include one compound selected from the group consisting of aromatic hydrocarbon compounds, ketone compounds, and acetate compounds, i.e., the one stomatal inducer may include any one compound selected from the group consisting of one aromatic hydrocarbon compound, one ketone compound, and one acetate compound.

[0089] The aromatic hydrocarbon compound may include an aromatic hydrocarbon compound or a derivative compound in which a part of hydrogen atoms contained in the aromatic hydrocarbon compound is substituted with another functional group. Specifically, the aromatic hydrocarbon compound may include an aromatic hydrocarbon compound having 6 to 20 carbon atoms substituted with one or more alkyl groups having 1 to 10 carbon atoms. In the aromatic hydrocarbon compound having 6 to 20 carbon atoms substituted with one or more alkyl groups having 1 to 10 carbon atoms, at least one or more alkyl groups having 1 to 10 carbon atoms, or 1 to 6, 1 to 5, or 1 to 4 alkyl groups having 1 to 10 carbon atoms may be substituted. Examples of the aromatic hydrocarbon compound are not particularly limited, but may include mesitylene, for example.

[0090] The ketone compound may include a ketone compound or a derivative compound in which some of the hydrogen atoms contained in the ketone compound are substituted with other functional groups. Specifically, the ketone compound may include an aliphatic ketone compound having 5 to 20 carbon atoms. Examples of the ketone compound are not particularly limited, but may include diisobutyl ketone, for example.

[0091] The acetate compound may include an acetate compound or a derivative compound in which some of the hydrogen atoms contained in the acetate compound are replaced with other functional groups. Specifically, the acetate compound may include an aliphatic acetate compound having 6 to 20 carbon atoms. Examples of the acetate compound are not particularly limited, but may include amyl acetate or hexyl acetate.

[0092] Meanwhile, the pore-inducing material may include a mixture of an alcohol-based compound and an aromatic hydrocarbon-based compound. The content of the pore-inducing material including a mixture of an alcohol-based compound and an aromatic hydrocarbon-based compound in the dispersed phase solution may be 10% to 80% by weight. If the content of the pore-inducing material is too low, less than 10% by weight, the average diameter of the pores in the porous polymer particles is too low, making it difficult to secure sufficient space for protein binding. On the other hand, if the content of the pore-inducing material is too high, more than 80% by weight, the average diameter of the pores in the porous polymer particles is too high, making it difficult to secure the strength of the particles.

[0093] On the other hand, the content of the aromatic hydrocarbon compound may be 10 parts by weight to 1000 parts by weight per 100 parts by weight of the alcohol compound. Within the above range, the pore size and particle size suitable for application to particles for protein purification can be satisfied.

[0094] The alcohol compound may have a carbon number of 11 or less, or 10 or less, or 1 or more, or 1 to 11, or 1 to 10. If the carbon number of the alcohol compound is excessively increased, such as exceeding 11, phase separation occurs too quickly in the dispersed phase during particle polymerization, and core-shell particles, rather than porous particles, may be formed. When purifying proteins, ligands to which the protein to be purified can be attached, are attached to the particle surface, but core-shell particles have fewer sites to which the ligand can be attached compared to porous particles, making them unsuitable for protein purification.

[0095] More specifically, the alcohol-based compound can include an aliphatic alcohol having 1 to 11 carbon atoms. The aliphatic alcohol having 1 to 11 carbon atoms may be substituted or unsubstituted, and if substituted, examples of the substituent are as described above.

[0096] Specific examples of the aliphatic alcohol having 1 to 11 carbon atoms are not particularly limited, but may include, for example, one or more compounds selected from the group consisting of 1-decanol, 1-butanol, 1-pentanol, 1-hexanol, 1-heptanol, 1-octanol, and 1-nonanol.

[0097] The aromatic hydrocarbon compound may have a carbon number of 11 or less, or 10 or less, or 6 or more, or 6-11, or 6-10. When an aliphatic hydrocarbon compound is used instead of the aromatic hydrocarbon compound, phase separation occurs too quickly in the dispersed phase during particle polymerization, so that core-shell particles, not porous particles, may be formed. When purifying a protein, a ligand to which the protein to be purified can be attached, is attached to the particle surface. However, core-shell particles have fewer sites to which the ligand can be attached compared to porous particles, making them unsuitable for protein purification.

[0098] The aromatic hydrocarbon compound may include an aromatic hydrocarbon compound having 6 to 8 carbon atoms substituted with an alkyl group having 1 to 3 carbon atoms. The aromatic hydrocarbon compound may include toluene.

[0099] In one example, the dispersed phase solution may contain 10 parts by weight to 1000 parts by weight, or 60 parts by weight to 500 parts by weight of the pore-inducing material, relative to 100 parts by weight of the monomer. Specifically, the lower limit of the content of the pore-inducing material, relative to 100 parts by weight of the monomer, may be, for example, 10 parts by weight or more, 60 parts by weight or more, 200 parts by weight or more, 250 parts by weight or more, 300 parts by weight or more, 350 parts by weight or more, 400 parts by weight or more, 450 parts by weight or more, or 500 parts by weight or more. In addition, the upper limit of the content of the pore-inducing material, relative to 100 parts by weight of the monomer, may be, for example, 1000 parts by weight or less, 550 parts by weight or less, 500 parts by weight or less, 450 parts by weight or less, 400 parts by weight or less, 350 parts by weight or less, 300 parts by weight or less, 250 parts by weight or less, or 200 parts by weight or less. When the content is within the above range, it is advantageous to stably form an emulsion and ensure particle strength and morphological characteristics due to a desired level of crosslinking.

[0100] The dispersed phase solution may further include an initiator. The type of the initiator is not particularly limited to a photopolymerization initiator or a thermal polymerization initiator, and various examples widely used in the conventional field of polymer particle manufacturing may be used without limitation, as long as the particle characteristics according to the manufacturing method of the present application are not hindered.

[0101] For example, ketone initiators, organic peroxide initiators, azo initiators, etc. can be used. Specifically, compounds such as 2,2-dimethoxy-2-phenylacetophenone, 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone, 1-hydroxycyclohexyl phenyl ketone, benzoyl peroxide, di-t-amyl peroxide, t-butyl peroxybenzoate, 2,5-dimethyl-2,5-di-(t-butylperoxy)hexane, 2,5-dimethyl-2,5-di-(t-butylperoxy)hexyne-3, di-cumyl peroxide, and mixtures thereof can be used, but are not limited thereto.

[0102] The content of the initiator is not particularly limited. An appropriate content of the initiator can be used at a level that does not prevent the desired particle properties from being obtained. For example, the initiator can be contained in an amount of 0.01 parts by weight or more, specifically 0.05 parts by weight or more, 0.10 parts by weight or more, 0.15 parts by weight or more, or 0.20 parts by weight or more, relative to 100 parts by weight of the dispersed phase solution. The upper limit of the content of the initiator can be, for example, 5.0 parts by weight or less, specifically 4.5 parts by weight or less, 4.0 parts by weight or less, 3.5 parts by weight or less, 3.0 parts by weight or less, 2.5 parts by weight or less, 2.0 parts by weight or less, 1.5 parts by weight or less, or 1.0 parts by weight or less.

[0103] The polymerization is carried out under conditions that do not prevent the securing of particle characteristics. For example, the temperature and stirring speed at which the polymerization is carried out can be appropriately controlled by those skilled in the art.

[0104] Meanwhile, the porous polymer particles may be a polymerization reaction product of droplets obtained by passing a dispersed phase solution and a continuous phase aqueous solution containing one or two pore-inducing substances, a monomer, and a crosslinking agent through a step emulsifier. Various types of O / W droplets can be prepared to have a uniform size using the step emulsifier. The dispersed phase solution and the continuous phase aqueous solution containing the pore-inducing substance, the monomer, and the crosslinking agent are the same as those described above.

[0105] In contrast, in the case of existing O / W droplet manufacturing equipment (e.g. batch suspension polymerization method) that is not a step emulsification equipment, the coefficient of variation of particle size increases sharply, and the deviation of particle size becomes large, which can cause non-uniformity problems.

[0106] The step emulsification device may include a first inlet for injecting a dispersed phase solution; a second inlet for injecting a continuous phase solution; a dispersed phase flow path through which the dispersed phase solution flows; a continuous phase flow path through which the continuous phase solution flows; and a microchannel through which the dispersed phase solution flows into the continuous phase flow path to form droplets.

[0107] In particular, the viscosity of the single pore-inducing material is low, so when passing through a step emulsifier to obtain droplets, the maximum droplet generation speed is high, the material does not stick to the inside of the step emulsifier, and droplets are generated smoothly even when used repeatedly, improving process efficiency.

[0108] In addition, the pore-inducing material containing a mixture of an alcohol-based compound and an aromatic hydrocarbon-based compound has low viscosity, so when passing through a step emulsifier to obtain droplets, the maximum droplet generation speed is high, the material does not stick to the inside of the step emulsifier, and droplets are smoothly generated even when used repeatedly, improving process efficiency.

[0109] The speed of the dispersed phase flowing through the dispersed phase flow channel may be, but is not limited to, 1 μl / min to 10 ml / min, and the speed of the continuous phase flowing through the continuous phase flow channel may be, but is not limited to, 0.1 μl / min to 100 ml / min.

[0110] Specifically, the porous polymer particles are obtained by a manufacturing method including the steps of passing a dispersed phase solution and a continuous phase aqueous solution containing one or two types of pore-inducing substances, a monomer, and a crosslinking agent through a step emulsifier, the steps including: injecting the dispersed phase solution into a first inlet; injecting the continuous phase solution into a second inlet; and causing the dispersed phase flowing through the dispersed phase flow path to flow into the continuous phase flow path through a microchannel to form droplets.

[0111] More specifically, referring to the following Figures 10 and 11, the step emulsification apparatus is fabricated by bonding together a silicon substrate 1 having a set emulsification pattern 10 formed thereon and a glass substrate 2 having first and second inlets 52, 54 and an outlet 56 formed thereon, and thermally oxidizing the bonded silicon substrate 1 and glass substrate 2.

[0112] When the emulsification device is prepared, the dispersed phase is injected into the dispersed phase supply section 22 of the dispersed phase channel 20 through the first injection port 52 (S210). Here, the dispersed phase may be mixed with a monomer, a crosslinking agent, an initiator, etc. depending on the purpose. The dispersed phase may be injected into the first injection port 52 by a syringe pump, but is not limited thereto. The dispersed phase injected into the dispersed phase supply section 22 through the first injection port 52 flows through the dispersed phase flow path 24. At this time, the speed of the dispersed phase may be, but is not limited thereto, 1 μl / min to 10 ml / min. The dispersed phase flowing through the dispersed phase flow path 24 flows into the continuous phase flow path 34 through a plurality of fine channels 40.

[0113] Furthermore, the continuous phase is injected into the continuous phase supply unit 32 of the continuous phase channel 30 through the second injection port 54 (S220). The continuous phase can be injected into the second injection port 54 by a syringe pump, but is not limited to this. The continuous phase injected into the continuous phase supply unit 32 through the second injection port 54 flows through the continuous phase flow path 34. At this time, the speed of the continuous phase may be, but is not limited to, 0.1 μl / min to 100 ml / min.

[0114] The dispersed phase flowing through the multiple microchannels 40 into the continuous phase flow path 34 meets the continuous phase flowing through the continuous phase flow path 34 and permeates into the continuous phase to form O / W droplets (S230).

[0115] The O / W droplets flow together with the continuous phase along the continuous phase flow path 34 to the discharge section 36 and are discharged to the outside of the emulsification device through the discharge port 56.

[0116] Meanwhile, in the step of polymerizing the droplets obtained in the step emulsification device, the polymerization can be either photopolymerization or thermal polymerization, and the polymerization reaction is carried out by adding a photopolymerization initiator or thermal polymerization initiator to the above-mentioned dispersed phase. Specific examples of the photopolymerization initiator or thermal polymerization initiator and specific conditions for the photopolymerization or thermal polymerization are not particularly limited, and various examples and conditions widely used in the conventional field of polymer particle manufacturing can be applied without limitation.

[0117] 2. Protein purification columns According to another embodiment of the present invention, there is provided a column for protein purification, comprising the porous polymer particles of the above embodiment. The contents relating to the porous polymer particles include all of the contents described above in the above embodiment.

[0118] The example of the protein is not particularly limited, and for example, an antibody drug can be used. The porous polymer particles can be used as beads used in the protein purification column, and other configurations and structures of the protein purification column can be any of various configurations and structures widely known in the field of existing purification columns without limitation. Effect of the Invention

[0119] According to the present invention, it is possible to provide porous polymer particles that are produced by a method with high production efficiency and have a particle size and pore size suitable for achieving high protein purification performance in a protein purification column, and a protein purification column using the same. [Brief description of the drawings]

[0120] [Figure 1] FIG. 2 shows SEM images of the porous polymer particles obtained in Example 1 (from left to right, the particle surface, the cross section of the outer periphery of the particle, and the cross section of the center of the particle). [Diagram 2] FIG. 2 shows SEM images of the porous polymer particles obtained in Example 2 (from left to right, the particle surface, the cross section of the outer periphery of the particle, and the cross section of the center of the particle). [Diagram 3] FIG. 2 shows SEM images of the porous polymer particles obtained in Example 3 (from left to right, the particle surface, the cross section of the outer periphery of the particle, and the cross section of the center of the particle). [Figure 4] FIG. 1 is a diagram showing an SEM image (particle surface) of the porous polymer particles obtained in Example 4. [Diagram 5] FIG. 1 is a SEM image of the porous polymer particles obtained in Example 5. [Figure 6] FIG. 1 is a SEM image of the porous polymer particles obtained in Example 6. [Figure 7] FIG. 1 is a SEM image of the porous polymer particles obtained in Example 7. [Figure 8] FIG. 2 shows SEM images of the porous polymer particles obtained in Comparative Example 1 (from left to right, the particle surface, the cross section of the outer periphery of the particle, and the cross section of the center of the particle). [Figure 9] FIG. 2 is a diagram showing an SEM image (particle surface) of the porous polymer particles obtained in Comparative Example 2. [Figure 10] FIG. 2 is a plan view of a first substrate of an emulsification device according to an embodiment of the present invention. [Figure 11] FIG. 2 is a plan view of a second substrate of an emulsification device according to an embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0121] The present invention will be described in more detail with reference to the following examples, however, the following examples are merely illustrative of the present invention and are not intended to limit the scope of the present invention.

[0122] <Examples and Comparative Examples: Production of Porous Polymer Particles> Examples 1 to 7 1) Preparation of the dispersive phase Glycidyl methacrylate (GMA) as a monomer, ethylene glycol dimethacrylate (EGDMA) as a crosslinker, and porogen as a pore-inducing material were mixed in a vial according to the materials and contents (content basis: 100% by weight of dispersed phase solution) shown in Table 1 below. Then, irgacure 651 as a photoinitiator was added to the vial at 1% by weight based on the weight of the mixed solution, and the mixture was stirred at room temperature for about 5 minutes to prepare a dispersed phase solution.

[0123] 2) Preparation of the continuous phase A continuous phase solution was prepared by dissolving sodium dodecyl sulfate (SDS) in DI water at a concentration of 0.5%.

[0124] 3) Production of porous polymer particles A connector was connected to a step emulsification microfluidic device, and a syringe pump was used to inject the dispersed phase into the first inlet 52 and the continuous phase into the second inlet 54. The dispersed phase was caused to flow through the dispersed phase flow channel 24 at a rate of 20 μl / min, and the continuous phase was caused to flow through the continuous phase flow channel 34 at a rate of 80 μl / min, generating fine droplets with a diameter of about 37 μm as measured by optical microscopy (see FIGS. 10 and 11 below).

[0125] The resulting droplets were collected in a 3% PVA (molecular weight 85,000-125,000) aqueous solution and shaken to disperse the droplets evenly in the solution, after which photopolymerization was carried out using a spot UV curing device to produce porous polymer particles.

[0126] Comparative Examples 1-2 1) Preparation of the dispersive phase A dispersed phase solution was prepared in the same manner as in the previous example, except that glycidyl methacrylate (GMA) was used as a monomer, ethylene glycol dimethacrylate (EGDMA) as a crosslinker, and a pore-inducing material (Porogen) were used as shown in Table 1 below (content basis: dispersed phase solution 100 wt%).

[0127] 2) Preparation of the continuous phase The continuous phase solution was prepared in the same manner as in the previous examples.

[0128] 3) Production of porous polymer particles Porous polymer particles were prepared in the same manner as in the above-mentioned Examples, except that the dispersed phase obtained in the above-mentioned Comparative Example was used.

[0129] Comparative Examples 3 to 4 As shown in Table 1 below, the oil phase was prepared by dissolving glycidyl methacrylate (GMA), ethylene glycol dimethacrylate (EDGMA) and initiator in a stomatal inducer solution at a volume ratio of 1:0.5 to the total volume of glycidyl methacrylate (GMA), ethylene glycol dimethacrylate (EDGMA) and initiator and stirring to form a transparent homogeneous mixed solution, as shown in the materials and contents (content basis: 100% by weight of dispersed phase solution) listed below in Table 1. The stomatal inducer solution was prepared by mixing n-hexane and dodecanol at a volume ratio of 1:1.

[0130] Then, polyvinyl alcohol (PVA) with a molecular weight of 1800 as a stabilizer and sodium dodecyl sulfate (SDS) as a surfactant were dissolved in deionized water to form a colorless, transparent, homogeneous mixed solution, thereby preparing an aqueous phase with a stabilizer concentration of 0.1% and a surfactant concentration of 3.0%.

[0131] The oil phase was added to the aqueous phase under mechanical stirring to carry out a polymerization reaction, and the reaction solution was washed with deionized water and ethanol in order to remove unreacted residues, and then vacuum dried at 70°C to produce porous polymer particles.

[0132] Reference example 1 1) Preparation of the dispersive phase The dispersed phase solution was prepared in the same manner as in Example 5.

[0133] 2) Preparation of the continuous phase A continuous phase solution was prepared in the same manner as in Example 5 above.

[0134] 3) Production of porous polymer particles The porous polymer particles were produced by a conventional batch suspension polymerization method without using the step emulsification microfluidic device.

[0135] <Experimental Example> The properties of the porous polymer particles obtained in the above Examples, Comparative Examples and Reference Examples were measured by the following methods, and the results are shown in Table 1.

[0136] 1.Epoxy content (1) Titration of experimental samples 0.1 g of the porous polymer particles obtained in the above Examples, Comparative Examples, and Reference Examples was mixed with 1 mL of HCl / acetone solution (volume ratio 1 / 40) and sonicated for 4 minutes. An indicator solution (0.1% cresol red and 0.1% thymol blue mixed in a volume ratio of 1:3, and adjusted to pH 7.0 with 0.01M NaOH) was added to the mixture. Titration with 0.1M NaOH was continued until the solution turned purple-blue.

[0137] (2) Titration of control samples The control samples were titrated in the same manner as the experimental samples, except that distilled water was used instead of the porous polymer particles obtained in the examples, comparative examples, and reference examples.

[0138] (3) Measurement of epoxy content The epoxy content in 1 g of the porous polymer particles was calculated using the following Equation 1.

[0139] [Formula 1] Epoxy content (μmol / g)=[(V0-V)×C NaOH ×1000] / W

[0140] In the above formula 1, V is the amount of NaOH (mL) used to titrate the experimental group samples containing porous polymer particles; V0 is the amount of NaOH (mL) used to titrate the control sample in which distilled water was used instead of the porous polymer particles in the experimental sample; C NaOH is the concentration of NaOH used in the titration (M), W is the mass (g) of the porous polymer particles used in the titration.

[0141] 2. Particle size and coefficient of variation The porous polymer particles obtained in the above Examples, Comparative Examples, and Reference Examples were observed at room temperature using an optical microscope to measure the particle diameter and its coefficient of variant (CV). Specifically, 100 particle samples were measured at room temperature using an optical microscope, and the diameter and coefficient of variant (CV) were calculated using the following Equation 2.

[0142] [Formula 2] Coefficient of variation (%) = (Standard deviation of particle size / Average particle size) x 100

[0143] 3. Pore size The pore size ranges of the particle surface, outer cut surface, and center cut surface of the porous polymer particles obtained in the examples, comparative examples, and reference examples were confirmed through SEM images (see FIGS. 1 to 9 below).

[0144] [Table 1]

[0145] -Mesitylene: Viscosity: 1.0 cP (20°C) -Diisobutyl ketone: Viscosity: 0.9 cP (20°C) -Amyl acetate: Viscosity: 0.9 cP (20°C) -Hexyl acetate: Viscosity: 1.2 cP (20°C) -1-Decanol: Viscosity: 12.0 cP (20°C) -Toluene: Viscosity: 0.56 cP (25°C) -N-butyl acetate: Viscosity: 0.685 cP (25°C) [Explanation of symbols]

[0146] 1: First board, 2: Second board 10: Emulsion pattern, 20: Dispersed phase channel 22: Dispersed phase supply section, 24: Dispersed phase flow path 30: continuous phase channel, 32: continuous phase supply section 34: Continuous phase flow path, 36: Discharge section 40: Microchannel, 52: First inlet 54: 2nd inlet, 56: outlet

Claims

1. A polymer matrix; and pores dispersed in said polymer matrix and having a diameter of 50 nm to 500 nm; Porous polymer particles having an epoxy content of 500 μmol or more and less than 5000 μmol per 1 g of the porous polymer particles as measured by the following Equation 1: [Formula 1] Epoxi content (μmol / g) = [(V 0 -V)×C 塩基 ×1000] / W In the above formula 1, V is the amount of base (mL) used to titrate the experimental group samples containing porous polymeric particles; V 0 is the amount (mL) of base used in titrating the control sample in which distilled water was used instead of the porous polymer particles in the experimental sample; C 塩基 is the concentration of base used in the titration (M), W is the mass (g) of the porous polymer particles used in the titration.

2. The porous polymer particle according to claim 1, wherein the pore size on the particle surface is 50 nm to 500 nm as measured by SEM.

3. The porous polymer particles according to claim 1, wherein the particle diameter of the porous polymer particles is 10 μm to 150 μm as measured by an optical microscope.

4. 2. The porous polymer particles according to claim 1, wherein the coefficient of variation of particle diameter measured by an optical microscope is 20% or less.

5. The porous polymer particle according to claim 1 , wherein the porous polymer particle is a particle for protein purification.

6. The porous polymer particles include 6. The porous polymer particle of claim 1, which is a polymerization reaction product of a dispersed phase solution and an aqueous continuous phase solution comprising one or two pore-initiators, a monomer, and a crosslinker.

7. The porous polymer particle according to claim 6 , wherein the one pore-inducing material comprises one compound selected from the group consisting of aromatic hydrocarbon-based compounds, ketone-based compounds, and acetate-based compounds.

8. The porous polymer particle according to claim 7 , wherein the aromatic hydrocarbon-based compound comprises mesitylene.

9. The porous polymer particle according to claim 7 , wherein the ketone-based compound comprises diisobutyl ketone.

10. The porous polymer particle of claim 7 , wherein the acetate-based compound comprises amyl acetate or hexyl acetate.

11. 7. The porous polymer particle according to claim 6, wherein the one pore-initiator has a viscosity measured at 20° C. of 0.5 cP to 15 cP.

12. 7. The porous polymer particle of claim 6, wherein the two pore-inducing substances comprise a mixture of an alcohol-based compound and an aromatic hydrocarbon-based compound.

13. The porous polymer particle according to claim 12, wherein the alcohol-based compound includes an aliphatic alcohol having 1 to 11 carbon atoms.

14. The porous polymer particle according to claim 12, wherein the aromatic hydrocarbon-based compound comprises an aromatic hydrocarbon compound having 6 to 8 carbon atoms substituted with an alkyl group having 1 to 3 carbon atoms.

15. 7. The porous polymer particle according to claim 6, wherein the content of the one or two pore-inducing substances in the dispersed phase solution is 10% by weight to 80% by weight based on 100% by weight of the dispersed phase solution.

16. 7. The porous polymer particle according to claim 6, wherein the content of the monomer in the dispersed phase solution is 10% by weight to 60% by weight based on 100% by weight of the dispersed phase solution.

17. 7. The porous polymer particle according to claim 6, wherein the content of the crosslinking agent in the dispersed phase solution is 10% by weight to 60% by weight based on 100% by weight of the dispersed phase solution.

18. The porous polymer particles include 2. The porous polymer particle according to claim 1, which is a polymerization reaction product of droplets obtained by passing a dispersed phase solution and a continuous phase aqueous solution containing one or two pore-inducing substances, a monomer, and a crosslinking agent through a step emulsifier.

19. The step emulsification device comprises: a first inlet for injecting the dispersed phase solution; a second inlet for injecting the continuous phase solution; a dispersed phase flow path through which the dispersed phase solution flows; a continuous phase flow path through which the continuous phase solution flows; and 20. The porous polymeric particle of claim 18, comprising: a microchannel through which a dispersed phase solution flows into a continuous phase flow path to form droplets.

20. A column for protein purification comprising the porous polymer particles according to claim 1.

Citation Information

Patent Citations

  • Ligand-bonded carrier and method for producing the same

    JP2010189290A

  • Purification method for target and mixed-mode carrier

    JP2016069329A

  • Device having micro flow channel, liquid conveyance system and particle production method

    JP2022028384A

  • Packing material for affinity chromatography

    JP5354094B2

  • Filling agent for affinity chromatography

    JP5998050B2